These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 16297163)
1. Chronic fatigue syndrome is associated with diminished intracellular perforin. Maher KJ; Klimas NG; Fletcher MA Clin Exp Immunol; 2005 Dec; 142(3):505-11. PubMed ID: 16297163 [TBL] [Abstract][Full Text] [Related]
2. Immunological abnormalities in patients with chronic fatigue syndrome. Tirelli U; Marotta G; Improta S; Pinto A Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837 [TBL] [Abstract][Full Text] [Related]
4. A novel flow cytometric assay focusing on perforin release mechanisms of cytotoxic T lymphocytes. Weren A; Bonnekoh B; Schraven B; Gollnick H; Ambach A J Immunol Methods; 2004 Jun; 289(1-2):17-26. PubMed ID: 15251408 [TBL] [Abstract][Full Text] [Related]
5. The defect of the perforin granule system in cytotoxic T lymphocytes of atopic patients--are perforin reduction and hyperreleasability of clinical relevance? Ambach A; Bonnekoh B; Gollnick H J Dtsch Dermatol Ges; 2003 Dec; 1(12):938-44. PubMed ID: 16285645 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. Brenu EW; van Driel ML; Staines DR; Ashton KJ; Hardcastle SL; Keane J; Tajouri L; Peterson D; Ramos SB; Marshall-Gradisnik SM J Transl Med; 2012 May; 10():88. PubMed ID: 22571715 [TBL] [Abstract][Full Text] [Related]
7. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Chiang SC; Theorell J; Entesarian M; Meeths M; Mastafa M; Al-Herz W; Frisk P; Gilmour KC; Ifversen M; Langenskiöld C; Machaczka M; Naqvi A; Payne J; Perez-Martinez A; Sabel M; Unal E; Unal S; Winiarski J; Nordenskjöld M; Ljunggren HG; Henter JI; Bryceson YT Blood; 2013 Feb; 121(8):1345-56. PubMed ID: 23287865 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of T- and NK-cell lymphoma cells is not dependent on a mature cytotoxic phenotype. Boehrer S; Schui DK; Chow KU; Hoelzer D; Mitrou PS; Weidmann E Leuk Lymphoma; 2002 Dec; 43(12):2363-8. PubMed ID: 12613525 [TBL] [Abstract][Full Text] [Related]
9. Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2. Konjevic G; Schlesinger B; Cheng L; Olsen KJ; Podack ER; Spuzic I Immunol Invest; 1995 Mar; 24(3):499-507. PubMed ID: 7540593 [TBL] [Abstract][Full Text] [Related]
10. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Huth TK; Staines D; Marshall-Gradisnik S J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723 [TBL] [Abstract][Full Text] [Related]
11. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Rivas JL; Palencia T; Fernández G; García M Front Immunol; 2018; 9():1028. PubMed ID: 29867995 [TBL] [Abstract][Full Text] [Related]
12. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. Curriu M; Carrillo J; Massanella M; Rigau J; Alegre J; Puig J; Garcia-Quintana AM; Castro-Marrero J; Negredo E; Clotet B; Cabrera C; Blanco J J Transl Med; 2013 Mar; 11():68. PubMed ID: 23514202 [TBL] [Abstract][Full Text] [Related]
13. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis. Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. Grom AA; Villanueva J; Lee S; Goldmuntz EA; Passo MH; Filipovich A J Pediatr; 2003 Mar; 142(3):292-6. PubMed ID: 12640378 [TBL] [Abstract][Full Text] [Related]
15. Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. Pár G; Rukavina D; Podack ER; Horányi M; Szekeres-Barthó J; Hegedüs G; Paál M; Szereday L; Mózsik G; Pár A J Hepatol; 2002 Oct; 37(4):514-22. PubMed ID: 12217606 [TBL] [Abstract][Full Text] [Related]
16. Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica. Ambach A; Bonnekoh B; Gollnick H J Allergy Clin Immunol; 2001 May; 107(5):878-86. PubMed ID: 11344356 [TBL] [Abstract][Full Text] [Related]
17. Cytolytic effector function is present in resting peripheral T lymphocytes. Geisberg M; Dupont B Int Immunol; 1992 Nov; 4(11):1273-81. PubMed ID: 1472478 [TBL] [Abstract][Full Text] [Related]
20. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity. Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]